2017 Executive Sponsors

Actigraph
Medidata

2017 Associate Sponsors

Aces Health
Blinded Diagnostics
Cmed
ePharmaSolutions
Medable Inc
mProve Health
Parallel 6, a PRA Health Sciences Company
Preventice Solutions
Science 37
Silver Cloud Health
TrialX

2017 Supporting Sponsor

THREAD

2017 Exhibitors

Biospective Inc
DataArt
MC10
Philips Respironics
Tactio Health Group

2017 Supporting Partner

Eureka

2017 Media Partners

Big3Bio
Biocompare
BioPharm Insight
CanBiotech
CenterWatch
Life Science Leader
Pharmalicensing
PharmaVOICE
Rebar Interactive
SciDoc Publishers
Technology Networks

Event Blog


  • November 16, 2017

  • Congratulations to our Friends at Otsuka and Proteus Digital

    Congratulations to our friends at Otsuka and Proteus Digital Health on FDA Approval of the 1st Digital Medicine System. We have worked with both Otsuka and Proteus on past DPharm conferences and it has been exciting to watch the advancements of not only the technology, but also the collaboration between these two companies and to […]

    Congratulations to our friends at Otsuka and Proteus Digital Health on FDA Approval of the 1st Digital Medicine System. We have worked with both Otsuka and Proteus on past DPharm conferences and it has been exciting to watch the advancements of not only the technology, but also the collaboration between these two companies and to see them cross the finish line to FDA approval. Their collective contribution to improving patient compliance helps raise the bar for the industry. For more information, please see the press release below.

    Press Release: Otsuka And Proteus® Announce The First U.S. FDA Approval Of A Digital Medicine System: ABILIFY MYCITE® (aripiprazole tablets with sensor)

    Debbie Profit, Otsuka, speaking at DPharm Europe

    Timothy Peters-Strickland, Otsuka, speaking at DPharm Europe

    Lorenzo DiCarlo, VP, Clinical and Medical Affairs, Proteus, speaking at DPharm Europe

    Read More

  • October 23, 2017

  • Podcast: From the Olympics to Clinical Research

    Pan American Games Champion, Olympian and World Championship silver medalist, Jennifer Goldsack, became a world-class athlete while working and studying at the University of Oxford. How did she do it? She recently shared her story with DPharm Director, Valerie Bowling, discussing the lessons she learned from her Olympic experience and how she uses them in her professional life at the Clinical […]

    Pan American Games Champion, Olympian and World Championship silver medalist, Jennifer Goldsack, became a world-class athlete while working and studying at the University of Oxford. How did she do it? She recently shared her story with DPharm Director, Valerie Bowling, discussing the lessons she learned from her Olympic experience and how she uses them in her professional life at the Clinical Trials Transformation Initiative (CTTI).JenniferGoldsack

    Ms Goldsack manages the development and implementation of Clinical Trials Transformation Initiative (CTTI) projects. In collaboration with team leaders, she creates project plans and budgets, and manages the implementation of those plans. She earned her master’s degree in chemistry from the University of Oxford, England, her masters in the history and sociology of medicine from the University of Pennsylvania, and her MBA from the George Washington University. Additionally, she is a certified Lean Six Sigma Green Belt and a Certified Professional in Healthcare Quality.

    Ms Goldsack spent five years working in research at the Hospital of the University of Pennsylvania, first in Outcomes Research in the Department of Surgery and later in the Department of Medicine. More recently, Ms Goldsack helped launch the Value Institute, a pragmatic research and innovation center embedded in a large academic medical center in Delaware.

    Ms Goldsack recently presented at the Mobile in Clinical Trials conference organized by the Conference Forum.

    Visit Pharma Talk Radio to listen to more episodes.

    Read More

  • September 6, 2017

  • 4th Annual Mobile in Clinical Trials @DPharm Recap

    The 4th annual Mobile in Clinical Trials event took place this week in Boston. Dr Daniel Karlin, Head of Experimental Medicine, Informatics & Regulatory Strategy at the Pfizer Innovative Research Lab, kicked off the event with an update on the use of mobile and digital tools in the clinical trials space. “What we do is […]

    The 4th annual Mobile in Clinical Trials event took place this week in Boston. Dr Daniel Karlin, Head of Experimental Medicine, Informatics & Regulatory Strategy at the Pfizer Innovative Research Lab, kicked off the event with an update on the use of mobile and digital tools in the clinical trials space.

    “What we do is really hard, and a lot of us have become allergic to hype, to under-promising and over-delivering,” Karlin told attendees. “I think we’ve done a lot this year. We’re starting to experience a real community of practice in this space.”

    This year’s Mobile in Clinical Trials event featured in-depth panel discussions, presentations and live demonstrations to illustrate the benefits of using mobile and digital tools in clinical trials.

    Highlights from the Mobile in Clinical Trials event included:

    1. Industry Leaders Discuss How to Overcome Cultural Barriers to Mobile Implementation

    Several industry leaders discussed what it takes to incorporate mobile and digital tools into a clinical trial during a panel discussion titled “Time to Commit: How to Overcome the Cultural Barriers to Mobile Implementation.” The discussion featured insights from the following clinical trials experts:

    Moderator:

    • Jeff Lee, CEO, mProve Health

    Panelists:

    • Munther Baara, Senior Director, Clinical Paradigm, Pfizer
    • Jacob LaPorte, PhD, Head of Digital Development, Novartis
    • Jane Myles, Head, Operational Intelligence and Innovation, Genentech/Roche
    • Alex Simmonds, Business Partner, Digital Clinical, R&D IT, Bristol-Meyers Squibb

    Healthcare professionals must realize there is no “one-size-fits-all approach” to mobile and digital implementation, Baara said. However, with a collaborative approach to state-of-the-art technologies, healthcare professionals can optimize the value of mobile and digital tools.

    “You’ve got to work bottom-up and top-down and ensure that stakeholders understand the implementation process and benefits of mobile and digital solutions,” Baara stated.

    Additionally, Myles recommended healthcare professionals evaluate a variety of mobile and digital tools. This approach enables healthcare professionals to determine which mobile and digital tools can help them achieve their desired goals.

    “Anyone can innovate on anything, but we need to figure out which things will work for us,” Myles noted.

    2. Verily’s Program Manager Examines the Scalability of Wearables in Clinical Trials

    Tushar Parlikar, Program Manager at Verily Life Sciences, discussed the requirements that healthcare professionals need to follow to scale the deployment of wearables in clinical trials during his Mobile in Clinical Trials presentation.

    According to Parlikar, there are three requirements for using wearables in clinical trials:

    • Collect a rich and complex data set.
    • Provide an engaging user experience.
    • Maintain the capacity to ingest and manage data for hundreds to thousands of devices.

    Furthermore, doing clinical trials at scale requires significant innovation and an ongoing commitment to drive meaningful, engaging patient interactions, Parlikar said.

    3. ActiGraph’s CTO Discusses How to Plan for Mobile Health

    Jeremy Wyatt, Chief Technology Officer and Senior Vice President of Product Development at ActiGraph, explained how healthcare professionals can plan for mobile health during his presentation to Mobile in Clinical Trials attendees.

    Ultimately, Wyatt offered seven steps to help healthcare professionals can plan for mobile health:

    • Start with the end in mind.
    • Identify meaningful clinical data (and understand that not all data is meaningful).
    • Consider working with an expert academic partner with past experience.
    • Plan for operational challenges such as battery life, data storage and wearablity issues.
    • Understand that a wearable is a component of an ecosystem.

    • Anticipate the overhead in dealing with monitoring continuous-time data.

    • Build partner-vendor relationships to deliver a comprehensive solution.  

    With this plan in place, healthcare professionals can leverage mobile technologies to drive patient engagement and improve clinical trial outcomes, Wyatt stated.   

    4. Medidata’s VP of mHealth Explores Digital Approaches to Patient Engagement

    Anthony Costello, Vice President of mHealth at Medidata, provided Mobile in Clinical Trials attendees with insights into digital approaches to patient engagement. In his presentation, “Designing an Effective eSource Strategy to Empower Patients with Technology,” Costello indicated mobile and digital technologies empower healthcare professionals to reduce clinical trial risks and increase study efficiency.

    Also, as more healthcare organizations explore integrations, the push for effective electronic data management will increase, Costello said. This may lead to additional hybrid eConsent implementation opportunities in the years to come.  

    “We’re starting to see a lot of hybrid implementation opportunities, especially internationally,” Costello pointed out. “As integrations become more common, electronic data management of consent information will become more necessary.”

    5. Healthcare Innovators Demonstrate Virtual Trial Model Options

    What is a virtual clinical trial? Healthcare innovators from various virtual trial model providers examined the question in detail as part of a panel discussion at the Mobile in Clinical Trials event.

    The panel discussion featured the following participants:

    • Angela Walker, Emergent Strategy Consultant, Clinical Innovation, Eli Lilly & Company
    • Noah Craft, MD, PhD, Co-founder and CEO, Science 37
    • Jeff Frazier, Founder and CEO, THREAD
    • Michelle Longmire, MD, Co-founder and CEO, Medable Inc.
    • David Turner Jr., MS, CISA, CEO, Parallel 6, a PRA Health Sciences company

    Virtual trials can help reduce the patient burden and improve the overall quality of a clinical trial, Turner said. Moreover, these trials may usher in a “new era of healthcare” by empowering healthcare professionals to collect and analyze mobile data like never before, Longmire indicated.

    Although virtual trials may become more prevalent in the near future, healthcare professionals cannot forget about patients’ needs. If healthcare professionals prioritize patient engagement and satisfaction, they can boost the likelihood of successful virtual trials.

    “Understanding what patients want before you start a trial is half the battle. The other half is keeping that going throughout a trial,” Craft stated. “You can overstep. … The key is to take the perspective of the consumer.”

    Next year’s Mobile in Clinical Trials event will take place Sept. 24 in Boston – stay tuned for additional details.

    Read More

  • August 25, 2017

  • PharmaTalkRadio: Why Pharma R&D has to Start Thinking Like a Service Industry and How?

    The Conference Forum is pleased to share a podcast featuring keynote speaker and world renowned customer service expert, Dr Chip Bell who spoke at the 6th annual DPharm: Disruptive Innovations to Advance Clinical Trials on the topic of service in clinical trials. To truly service our patients, we need to understand service together with science. Can service be a […]

    The Conference Forum is pleased to share a podcast featuring keynote speaker and world renowned customer service expert, Dr Chip Bell who spoke at the 6th annual DPharm: Disruptive Innovations to Advance Clinical Trials on the topic of service in clinical trials.

    To truly service our patients, we need to understand service together with science. Can service be a disrupter in clinical research? In this keynote, Dr Bell tells us how to think like a service industry, why it’s worth it for R&D and how to get started. Dr Bell gives the listener practical insights on how to give patients a great experience. Although this podcast is primarily focused on serving patients in clinical research, you will find that hospitals and physician offices/medical groups will also benefit.

    The 7th annual DPharm conference will continue to cover service, but through a patient perspective. DPharm 2017 takes place September 7-8 in Boston. For more information, click here.

    About Dr Chip Bell:
    Dr Bell is considered a world-renowned authority on customer loyalty and service innovation. He has authored eight national best-selling books. For more information visit, www.chipbell.com.

     

    Read More

  • August 14, 2017

  • UCSF’s Revolutionary Health eHeart Mobile Clinical Study: Three Years On

    In 2014, UCSF’s Health eHeart study set out to revolutionize the way we predict, prevent, track and treat heart disease through the use of mobile technology. Three years ago at Mobile in Clinical Trials 2014, Carol Maguire of UCSF’s Division of Cardiology spoke about the aim to gather more data about heart health from more […]

    In 2014, UCSF’s Health eHeart study set out to revolutionize the way we predict, prevent, track and treat heart disease through the use of mobile technology. Three years ago at Mobile in Clinical Trials 2014, Carol Maguire of UCSF’s Division of Cardiology spoke about the aim to gather more data about heart health from more people than any research study ever before.

    We are delighted to welcome Carol back to the 4th annual Mobile event to give us a progress report in her session on the trials and tribulations of an ongoing mobile clinical study. Hear about what the obstacles and challenges have been and how they are being managed. With 122,871 participants to date, 16 studies in progress and 6 research studies published using their data, the program is on track to produce meaningful results and benefits.

    In the session, Carol will deliver an update on:

    • Where they are now
    • Challenges they have faced, both expected and unexpected
    • Lessons learned, including those around geo-fencing
    • Insights and realities in getting their data validated
    • Strategies for integrating multiple digital components in a study
    • What’s next, including The Eureka Research Platform

    Carol Maguire
    Carol Maguire, RN


    Director of Clinical Research, UCSF Division of Cardiology

    Mobile in Clinical Trials takes place on September 6 in Boston. For more information, please click here.

    Read More

  • August 11, 2017

  • The Findings are in! CTTI delivers their Recommendations on Integrating Mobile Technology into Clinical Trials at the Mobile Conference

    Most of us are aware that Mobile technology offers tremendous potential for clinical research, but uncertainty exists about how to use the data that can be captured. CTTI’s newly released recommendations and tools present a pathway for using the information gathered from mobile technologies to accelerate the development and evaluation of urgently needed therapies. We […]

    Most of us are aware that Mobile technology offers tremendous potential for clinical research, but uncertainty exists about how to use the data that can be captured. CTTI’s newly released recommendations and tools present a pathway for using the information gathered from mobile technologies to accelerate the development and evaluation of urgently needed therapies.

    We are delighted to welcome Jennifer Goldsack, MChem, MA, MBA, CPHQ, Clinical Project Manager, CTTI, to the 4th annual Mobile in Clinical Trials event to talk about CTTI’s Mobile Clinical Trials program. Launched three years ago, the program aims to develop recommendations to help develop novel endpoints for use in clinical trials from data generated using mobile technology.

    Jennifer shares recommendations and insights from CTTI’s Novel Endpoints Project on:

    • Developing an internal process for identifying endpoints
    • Strategies for reducing friction throughout the process
    • Executing the process
    • The science required to validate an endpoint
    • A suite of tools developed in the process to help facilitate implementation


    Jennifer Goldsack, MChem, MA, MBA, CPHQ

    
Clinical Project Manager, CTTI

    Mobile in Clinical Trials takes place on September 6 in Boston. For more information, please click here.

    Read More

  • August 9, 2017

  • The Conference Forum confirms agenda for the 4th annual Mobile in Clinical Trials event on September 6, 2017

    The Mobile in Clinical Trials one-day program delivers its annual update on the latest progress in applying mobile/digital tools to clinical trials and how to get it done. The Conference Forum has confirmed the one-day agenda for the Mobile in Clinical Trials event, which will take place on September 6, 2017 at the Marriott Copley Place in Boston, MA. Returning as […]

    The Mobile in Clinical Trials one-day program delivers its annual update on the latest progress in applying mobile/digital tools to clinical trials and how to get it done.

    The Conference Forum has confirmed the one-day agenda for the Mobile in Clinical Trials event, which will take place on September 6, 2017 at the Marriott Copley Place in Boston, MA.
    Returning as program chair is Daniel Karlin, MD, Head of Experimental Medicine, Informatics, and Regulatory Strategy, Pfizer Innovative Research Lab, Pfizer, who leads 19 industry speakers in discussing how and when to implement mobile/digital technology in clinical trials and the potential benefits to be gained.

    “Now in its fourth year, the Mobile program brings together speakers from key contributors to the development of digital technology in clinical trials,” says Conference Producer, Jennifer Moran. “Scheduled immediately before the 7th annual DPharm: Disruptive Innovations to Advance Clinical Trials conference at the same venue, this full-day event provides an ideal opportunity to discover more about the value of using digital tools in drug development.”

    The event starts with opening remarks by chair Dan Karlin. The morning includes sessions on: how to overcome the cultural barriers to implementing mobile technology; CTTI’s findings on their mobile clinical trials program and recommendations on novel endpoints; case study learnings from Medidata; FDA guidance on implementing digital/mobile strategies and tools in clinical research; GSK’s PARADE study; Roche’s Parkinson’s disease study; and new technologies in live five-minute demonstrations.

    The afternoon sessions cover: how to introduce digital tools in a clinical trial from start to finish; demonstrating value-added to a Phase IV trial by introducing a valid wearable; the current realities of the virtual trial model; Verily’s study watch tackling the scalability of wearables in clinical trials; the why, what, where and how of the digital coach in clinical trials; and a call to action and reflection on the the day’s learnings.

    Find out more about Mobile in Clinical Trials.

    Read More

  • May 26, 2016

  • Mobile in Clinical Trials Agenda Announced!

    The 3rd Annual Mobile in Clinical Trials program agenda is published! The 2016 event takes place September 19th at the Fairmont Copley Plaza Hotel Boston. The theme for 2016 is implementation, scale up and making mobile a reality finally in drug development. We are delighted to welcome back Pfizer’s Dr Dan Karlin, Human Biology Lead, […]

    The 3rd Annual Mobile in Clinical Trials program agenda is published! The 2016 event takes place September 19th at the Fairmont Copley Plaza Hotel Boston. The theme for 2016 is implementation, scale up and making mobile a reality finally in drug development.

    2016 Chair Dan Karlin, Pfizer

    Dr Dan Karlin at the 2nd Annual Program

    We are delighted to welcome back Pfizer’s Dr Dan Karlin, Human Biology Lead, Computational Neuromedicine and Human Biology as conference chair.

    Key topics being covered in 2016 are:

    • Identifying the current barriers and addressing how to overcome them once and for all
    • The Influence of Mobile Data on Investigative Decisions led by Roche
    • Rethinking How we Use Sensors in Clinical Trials with Pfizer & Otsuka
    • MIT and Eli Lilly on How to Reinterpret the Cognition Scale in a Digital Era?
    • How to Get a New Technology Written Into an Upcoming Protocol: Science 2.0
    • ResearchKit: Where Are They Now and Where are the Real Benefits?
    • Addressing the limitations of the Research Kit and how to Close the Gaping Holes
    • Overcoming Intellectual property delays further adoption of mobile devices with Biogen Idec.
    • mProve Health on considerations when planning a pilot for a BYOD study
    • The NHSA on integrated approaches to using digital as a clinical tool as one source for everyone to access,

    Click here for more information on the agenda.

    Read More

  • July 31, 2015

  • Consumer Electronics in Clinical Research on PharmaTalkRadio

    Join PharmaTalkRadio as we address and explore an update on what’s available, what’s capable and what’s working with consumer electronics in clinical research. We explore topics including, but not limited to: – How to scale new tools – The level of validation of different instruments – The impact of tools like the Apple Research Kit […]

    Join PharmaTalkRadio as we address and explore an update on what’s available, what’s capable and what’s working with consumer electronics in clinical research. We explore topics including, but not limited to:

    • – How to scale new tools
    • – The level of validation of different instruments
    • – The impact of tools like the Apple Research Kit
    • – What future apps will offer

    Hosted by Craig Lipset, Head of Clinical Innovation R&D at Pfizer with guest speakers: Rahlyn Gossen, Founder, Rebar Interactive, Michael Luker, Director, Clinical Innovation, Eli Lilly and Katherine Vandebelt, Senior Director, Clinical Development Innovation, Eli Lilly

    Listen to the show HERE

    *Please note this session has some background sound interference at the start of the program. The opinions shared by our guests are those of the speakers and do not necessarily reflect the opinions of their employers.

    For more about the Apple Research Kit as well as mobile’s rise from promise to power join Craig and Rahlyn at Mobile in Clinical Trials, September 9th in Boston.

    For more information visit: http://theconferenceforum.org/conferences/mobile-in-clinical-trials/overview

     

    Read More

  • August 26, 2014

  • Medtech Boston talks with Valerie Bowling about Conference Forum events

    If you’re interested in disruptive innovations in clinical trials or drug delivery, Boston is prime real-estate. That’s why The Conference Forum will be hosting four major events in September and October 2014: Mobile and Clinical Trials; Global Clinical Trials; DPharm: Disruptive Innovations to Advance Clinical Trials; and Partnerships in Drug Delivery. We caught up with […]

    If you’re interested in disruptive innovations in clinical trials or drug delivery, Boston is prime real-estate. That’s why The Conference Forum will be hosting four major events in September and October 2014: Mobile and Clinical Trials; Global Clinical Trials; DPharm: Disruptive Innovations to Advance Clinical Trials; and Partnerships in Drug Delivery. We caught up with conference director Valerie Bowling to find out about these meetings. Click here for more…
    http://medtechboston.medstro.com/conference-forum-events-in-boston-to-focus-on-clinical-trial-innovation/

    Read More

  • June 6, 2014

  • Dr Joris Van Dam, Novartis Appointed Chair of the Inaugural Mobile and Clinical Trials Event

    The Conference Forum is thrilled to announce the appointment of Joris Van Dam, PhD, Strategic Projects Leader, Pharmaceutical Development at Novartis as the Chair for the inaugural Mobile and Clinical Trials event. This new one-day program taking place September 10th in Boston helps drug developers get their arms around the mobile/digital clinical trial landscape. Topics addressed include […]

    The Conference Forum is thrilled to announce the appointment of Joris Van Dam, PhD, Strategic Projects Leader, Pharmaceutical Development at Novartis as the Chair for the inaugural Mobile and Clinical Trials event. This new one-day program taking place September 10th in Boston helps drug developers get their arms around the mobile/digital clinical trial landscape. Topics addressed include how mobile is innovating clinical trials, overcoming behavioral and technical hurdles, the investment climate, the true value of mobile to clinical trials, amongst others.

     

    Joris van Dam B&W

    Joris is a corporate entrepreneur in pharmaceutical R&D, focusing on clinical trial innovation and improving health outcomes through the use of disruptive technologies. For the past three years, he started a number of initiatives under the “Trials of the Future” program at Novartis, including the Patients-2-Trials Consortium, and the Clinical Research Collaboration with Walgreens. Prior to that, Joris spent seven years at Johnson & Johnson and seven years in consulting and business development.

     

    For more information about the Mobile and Clinical Trials event, please visit, www.theconferenceforum.org

    Read More